Compound ID | 2911
Class: Drug efflux pump inhibitor
| Agent Type: | Synthetic; Small molecule; Direct acting; Antibiotic adjuvant; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Efflux pump inhibitor. AcrB inhibitor |
| Target Pathogen: | Active against Klebsiella pneumoniae with levofloxacin including against AcrAB-TolC overexpression strains (RamR mutants) |
| Description: | Synthetic compound; pyridylpiperazine-based compound; combination with levofloxacin improves Klebsiella pneumoniae clearance in mouse than levofloxacin alone |
| Year first mentioned: | 2023 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/166485295 |
| Citation: | https://www.embopress.org/doi/full/10.1038/s44321-023-00007-9 |